Nobuo Hatori
Odawara, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease.
Journal: Diabetes, obesity & metabolism
Published: March 11, 2024
Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP study.
Journal: Frontiers in pharmacology
Published: December 20, 2023
Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medication.
Journal: Diabetes & vascular disease research
Published: December 14, 2023
Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: August 02, 2023
The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor agonists.
Journal: Cardiovascular endocrinology & metabolism
Published: May 29, 2023
Cross-sectional survey of hypertension management in clinical practice in Japan: the Kanagawa Hypertension Study 2021 conducted in collaboration with Japan Medical Association Database of Clinical Medicine.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: March 02, 2023
The Proportion of Long-term Response to Anti-N IgG Antibody after 12 Months for COVID-19 Subclinical Infections and a Longitudinal Survey for COVID-19 Subclinical Infections in 2021.
Journal: Internal medicine (Tokyo, Japan)
Published: August 09, 2022
The influence of Japanese general practitioners' familiarity with nephrologists on the management of chronic kidney disease.
Journal: Journal of nephrology
Published: June 12, 2022
Comparison of the blood pressure management between sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists.
Journal: Scientific reports
Published: June 05, 2022
Comparison of the 2013 and 2019 Nationwide Surveys on the Management of Chronic Kidney Disease by General Practitioners in Japan.
Journal: Journal of clinical medicine
Published: June 05, 2022
Long-term outcome and risk factors associated with events in patients with atrial fibrillation treated with oral anticoagulants: The ASSAF-K registry.
Journal: Journal of cardiology
Published: May 05, 2022
Concomitant treatment with insulin and sodium-glucose cotransporter 2 inhibitors was associated with the renal composite outcome in Japanese patients with type 2 diabetes and chronic kidney disease: A propensity score-matched analysis.
Journal: Journal of diabetes investigation
Published: March 29, 2022
Last Updated: 09/26/2026